R4 Ballot #1 (Mixed Normative/Trial use) Current Build
This page was published as part of FHIR v3.3.0: R4 Ballot #1 : Mixed Normative/Trial use (First Normative ballot). It has been superceded by R4 . For a full list of available versions, see the Directory of published versions .

Riskassessment-example-breastcancer.json

Clinical Decision Support Work Group Maturity Level : N/A Ballot Standards Status : Informative Compartments : Device , Patient , Practitioner

Raw JSON ( canonical form + also see JSON Format Specification )

Breast cancer risk assessment

{
  "resourceType": "RiskAssessment",
  "id": "breastcancer-risk",
  "text": {
    "status": "additional",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <table>\n        <tr>\n          <td colspan=\"2\">\n            <h1>Information about your risk score:</h1>\n          </td>\n        </tr>\n        <tr>\n          <td>\n            <strong>Birthdate:</strong>\n          </td>\n          <td>1981-01-01</td>\n        </tr>\n        <tr>\n          <td>\n            <strong>Gender:</strong>\n          </td>\n          <td>female</td>\n        </tr>\n        <tr>\n          <td>\n            <strong>Ethnicity:</strong>\n          </td>\n          <td>Unknown / Not Reported</td>\n        </tr>\n      </table>\n    </div>"
  },
  "identifier": [
    {
      "use": "official",
      "system": "http://example.org",
      "value": "risk-assessment-breastcancer1"
    }
  ],
  "status": "final",
  "code": {
    "coding": [
      {
        "system": "http://browser.ihtsdotools.org/",
        "code": "709510001",
        "display": "Assessment of risk for disease (procedure)"
      }
    ]
  },
  "subject": {
    "reference": "Patient/example"
  },
  "performer": {
    "reference": "Practitioner/example"
  },
  "basis": [
    {
      "reference": "Observation/example-genetics-brcapat"
    }
  ],
  "prediction": [
    {
      "outcome": {
        "text": "Unknown risk of developing breast cancer"
      }
    }
  ],
  "note": [
    {
      "text": "This risk assessment is based on BRCA1 and BRCA2 genetic mutation test"
    }
  ]
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.